Turkey Regulatory Update: Industry Warns on Euro rate, Political Ambitions Thwarted
This article was originally published in PharmAsia News
Executive Summary
The chairman of the Pharmaceutical Manufacturers Association of Turkey (IEIS) has said that the cost of not updating the Euro exchange rate for the industry has exceeded $6.1 billion, while the ex-president of the SGK, who resigned her post to become an MP candidate for the June elections, has not been nominated. Four drugs have been added to the reimbursement list.